2 ms·
> If it were meaningless, FDAs and other regulatory bodies would not even accept it during the clinical trial design review phase. Billions in R&D goes to get
by nabla9 7y ago
> If it were meaningless, FDAs and other regulatory bodies would not even accept it during the clinical trial design review phase.
Billions in R&D goes to getting molecular entities approved by FDA that are clinically meaningless. The medical R&D is done just to get a product that provides already existing functionality or already existing treatment with a slightly modified molecule that can be patented.
It's like the joke about man who goes to patent office and says that he invented gunpowder. Patent clerk says that unfortunately gunpowder has already been invented. The man says: "But I invented more of it." Approval process is not looking if the new drug is meaningful improvement over existing drugs. "Inventing more of the same" is approved if it can be tweaked a little to be unique.
Alternative is also true. There are potentially clinical treatments and medicines that receive no approvals because there is no profit motive to push them trough the expensive process of approval.
- galangalalgol 7y agohow do they get doctors to prescribe the patented versions if they aren't better?
- mattmcknight 7y agoSometimes they pay other companies not to make the unpatented drug: https://www.ftc.gov/news-events/media-resources/mergers-competition/pay-delay https://www.ftc.gov/news-events/media-resources/mergers-comp... More tricks here: https://hbr.org/2017/04/how-pharma-companies-game-the-system-to-keep-drugs-expensive https://hbr.org/2017/04/how-pharma-companies-game-the-system...
- kyokpae 7y agoSales reps bribe doctors, plain and simple. https://www.vice.com/en_us/article/pg7ez9/pharma-reps-are-basically-bribing-your-doctor-study-confirms https://www.vice.com/en_us/article/pg7ez9/pharma-reps-are-ba...
- deleted 7y ago[deleted]
- nabla9 7y agoIf there is once choice, doctors prescribe it. If there are two or more very similar choices, doctors prescribe one or the other. Adding competition decreases price, sometimes there may slight differences in side effects. May not be worth of the research itself, but getting into market justifies it. Example: Great discovery: PDE5 inhibitor helps with erectile dysfunction. Product: sildenafil (Viagra). After the mechanism was invented, tadalafil (Cialis), and vardenafil (Levitra) were pushed into market and FDA approved. There are roughly different 10 PDE5 inhibitors and the market is saturated.
- dreamcompiler 7y agoDrug salespeople constantly cajole doctors to prescribe one drug over the other using soft bribes like prizes, kickbacks, junkets, etc. Doctors have very limited time to do research and prescribe mostly on the basis of what sales people recommend and what patients ask for (which itself comes from drug advertisements). The "betterness" of a drug has very little to do with what doctors prescribe. This phenomenon is quite well-documented so I won't cite sources here.